Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
about
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trialCerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and PreventionTransabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix.Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysisPatients with an asymptomatic short cervix (<or=15 mm) have a high rate of subclinical intraamniotic inflammation: implications for patient counseling17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial.Clinical significance of early (< 20 weeks) vs. late (20-24 weeks) detection of sonographic short cervix in asymptomatic women in the mid-trimester.Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient dataCervical tissue engineering using silk scaffolds and human cervical cellsCervical strain determined by ultrasound elastography and its association with spontaneous preterm deliverySecond trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproateMaternal characteristics influencing the development of gestational diabetes in obese women receiving 17-alpha-hydroxyprogesterone caproate.Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle.Progesterone withdrawal promotes remodeling processes in the nonpregnant mouse cervixA novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor.Progestin treatment for the prevention of preterm birth.Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birthMaternal Whole Blood Gene Expression at 18 and 28 Weeks of Gestation Associated with Spontaneous Preterm Birth in Asymptomatic Women.Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.Beyond Cervical Length: A Pilot Study of Ultrasonic Attenuation for Early Detection of Preterm Birth RiskComparative Study of Vaginal versus Intramuscular Progesterone in the Prevention of Preterm Delivery: A Randomized Clinical TrialAssessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancyMedroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birthIs sonographic assessment of the cervix necessary and helpful?Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysisComparison of the mechanisms responsible for cervical remodeling in preterm and term labor.The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester.Estrogen and progesterone metabolism in the cervix during pregnancy and parturitionVaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study.Preterm Birth Prevention: Effects of Vaginal Progesterone Administration on Blood Flow Impedance in Uterine-Fetal Circulation by Doppler Sonography.The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnanciesVaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last.Progesterone to prevent preterm birth in twin gestations: what is the next step forward?Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trialActions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth.Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate.The role of progesterone in maternal and fetal medicine.
P2860
Q24622553-974F5E83-AD7A-4643-BB8A-68DA39641928Q30235534-02FCB9EE-6E0A-40C6-9814-EA72F983B347Q30464228-74F8055B-B61F-4515-92BD-92DA4597E09FQ30702434-6F1078DE-F858-42D1-8CAF-76E58EC713C0Q33794307-473FA13C-7EB5-4C20-BDCE-1AFE4FCA40A0Q33886845-F254BAF9-20C5-4D9D-8074-B32391E700EFQ34080320-66D136F1-690B-4580-84F7-3E4D4095B344Q34113982-219975EC-956A-4BF1-8A1A-9A121B68AB32Q34118250-7A8932A8-A4F8-427F-90A5-DE3A29984C57Q34143212-3CBD26DB-F8A3-4FC2-879A-A401C8599157Q34171382-20149258-F9DB-4575-8F37-916FE80EE3B0Q34281817-B996441F-CE1B-43B2-8787-BF82E722175AQ34392086-FE371C14-A1BF-4F1F-B3E4-444B8E3EC642Q34487386-C748C635-5320-4536-83BE-08A674B98036Q34620970-BF88275F-E475-4B25-A5D7-F3BAA2DDC330Q34979402-7E3F9407-13EB-400D-B757-CAC57A72FE12Q35156867-BD9B7877-A2A7-4902-85F4-036FA0188434Q35223822-3EC89960-F69F-42A4-ADDA-294D668A40F8Q35703067-FA921940-D5BC-45E0-BE9C-B8F630956907Q36059037-7B32391A-89A3-47CF-A6EA-5D666DC133EDQ36095536-E28A8DB7-F8D1-41E8-B1F9-B881FB2210A0Q36122450-C4002405-FC7E-4FB3-91FB-F4D46C8F9419Q36217310-AC818B50-4BF6-4CE0-89B6-2E015B0DCA44Q36279075-51D44C22-5B15-44A0-9FC0-9EF75F7ADB93Q36311625-FEE30A28-D3BC-4280-BA93-6BEBB8DBF783Q36328567-4606BB01-F100-4910-8F6A-80DCCF991536Q36464938-9846D12F-6D74-42C1-95E6-62FF1FAF45FAQ36487287-F3CB498D-3C93-44B0-8ADF-F2CF6A38C4C1Q36636728-8719BE13-D48B-4C3A-B409-837BB4FE26ACQ36692485-5B4B7282-999B-4960-A1C5-1947EB06EBC8Q36732634-D4D4EE9C-FD27-4861-9AA9-C6DE0FE0B0D6Q37010395-AEEC1D59-F9BD-4FEB-8ACF-2E4506D48EAFQ37137051-802EE7D6-3258-4AB4-84E2-A2A11DA0A87AQ37381190-EDC73FF3-45DC-4EED-953B-5D20BF2B8DEEQ37486770-1189291D-ECD6-49E7-B426-23ABA5CB4CEBQ37487072-6C53963E-CC8B-4466-97D1-46D586563565Q37498149-C4E624A0-2D7E-4FD8-994C-431F40EC1AA1Q37704144-2ECF83E3-48C8-44B4-BCF6-AD4EF5471323Q37709667-ED90018E-E9B5-4D25-8F5B-4CCD9DB83C1FQ38051406-DF772320-4C37-4AD9-9EA9-0521212C5170
P2860
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@ast
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@en
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@nl
type
label
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@ast
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@en
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@nl
prefLabel
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@ast
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@en
Vaginal progesterone is associ ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P356
P1476
Vaginal progesterone is associ ...... lind, placebo-controlled trial
@en
P2093
Chazotte C
DeFranco EA
Khandelwal M
P2860
P304
P356
10.1002/UOG.5159
P577
2007-10-01T00:00:00Z